< Go back

Webinar: Breast Tumor Cryoablation with the ProSense System: ICE3 Study Update with Dr. Fine.


Dr. Richard E. Fine, MD, FACS presents the technology and techniques behind breast tumor cryoablation using the liquid nitrogen (LN2) based ProSense System. In this webinar, Dr. Fine presents an in-depth look at the positive interim results of the landmark ICE3 clinical trial on cryoablation of small, low-risk breast cancers. 

Webinar participants will: 

  • Learn about the technology and techniques behind Liquid Nitrogen (LN2) based cryoablation with the ProSense™ System
  • Understand patient benefits of cryoablation
  • Get updated ICE3 clinical trial interim results.